The notices it replaced
- Reissues: RFA-MH-18-702 Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)
- 2 steps back: RFA-MH-17-600 Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
Replaced by PAR-25-184.
Who won it before
25 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $26,411,493 in first-year total cost, median $968,769.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-B (01)]4
- Special Emphasis Panel[ZMH1 ERB-R (02)]4
- Special Emphasis Panel[ZMH1 ERB-D (02)]3
- Special Emphasis Panel[ZMH1 ERB-R (03)]3
- Special Emphasis Panel[ZMH1 ERB-S (06)]3
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN DIEGO5
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2
- CENTRE FOR ADDICTION AND MENTAL HEALTH1
- CINCINNATI CHILDRENS HOSP MED CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Cannabidiol-enhanced cognitive behavioral therapy for generalized anxiety disorder1R61MH137105-01A1 | LUNDAHL, LESLIE HMARUSAK, HILARYRABINAK, CHRISTINE ANNE | WAYNE STATE UNIVERSITY, MI | $1,715,387 | ZMH1 |
| 2025 | Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness1R61MH139856-01 | EVINS, A EDENWHITFIELD-GABRIELI, SUSAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,461,016 | ZMH1 |
| 2025 | Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia1R61MH138703-01A1 | DU, XIAOMINGHONG, L ELLIOT ELLIOT | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $1,125,194 | ZMH1 |
| 2025 | Maintenance rTMS for depression (Maitr-De)1R61MH138647-01 | DASKALAKIS, ZAFIRIS J. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $968,769 | ZMH1 |
| 2024 | Engaging the subgenual cingulate with brain stimulation for depression1R61MH135428-01 | OATHES, DESMOND | UNIVERSITY OF PENNSYLVANIA, PA | $1,633,082 | ZMH1 |
| 2024 | Noninvasive modulation of deep brain circuits for treatment-resistant depression1R61MH134943-01 | KUBANEK, JANMICKEY, BRIAN JAMES | UNIVERSITY OF UTAH, UT | $967,781 | ZMH1 |
| 2024 | Modulating spinal interoceptive pathways to evaluate their role and therapeutic potential in MDD symptomatic domains1R61MH133770-01A1 | ROMO-NAVA, FRANCISCO | UNIVERSITY OF CINCINNATI, OH | $898,025 | ZMH1 |
| 2024 | Mindfulness Engaged Neurostimulation for Depression (MEND)1R61MH136135-01 | MISHRA, JYOTIRAMANATHAN, DHAKSHIN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $888,768 | ZMH1 |
| 2024 | Ketogenic Diet in Weight Recovered Anorexia Nervosa to Target Metabolism and Normalize Persistent Eating Disorder Psychopathology1R61MH134909-01A1 | FRANK, GUIDO KW | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $884,103 | ZMH1 |
| 2024 | ADHD PreSMART: ADHD PreSMA Response inhibition Therapy1R61MH135994-01 | WU, STEVE WEI | CINCINNATI CHILDRENS HOSP MED CTR, OH | $671,533 | ZMH1 |
| 2024 | Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment1R61MH128390-01A1 | CHEN, SHUODU, XIAOMINGHONG, L ELLIOT ELLIOT | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $565,921 | ZMH1 |
| 2023 | Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection1R61MH129380-01A1 | SCHNEIER, FRANKLIN R.TAYLOR, CHARLES | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $1,423,718 | ZMH1 |
| 2023 | Using Ketamine to enhance memory reconsolidation and extinction of overgeneralized fear in individuals diagnosed with PTSD1R61MH129559-01A1 | HARPAZ-ROTEM, ILAN | YALE UNIVERSITY, CT | $1,241,319 | ZMH1 |
| 2023 | Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD1R61MH133666-01 | BENITO, KRISTEN GCONELEA, CHRISTINE A | EMMA PENDLETON BRADLEY HOSPITAL, RI | $1,224,725 | ZMH1 |
| 2023 | Suicide Circuit Therapeutics: Engaging Novel Targets with Rapid and Individualized MRI-Guided Accelerated TMS1R61MH132869-01 | CAMPRODON, JOAN A | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,169,931 | ZMH1 |
| 2023 | Frequency and E-field Enhancement of iTBS for Depression (FREED)1R61MH129471-01A1 | DASKALAKIS, ZAFIRIS J.FITZGERALD, PAUL | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $804,239 | ZMH1 |
| 2021 | Individually targeted neuromodulation for contamination-based OCD1R61MH121640-01A1 · under RFA-MH-18-702 | BRENNAN, BRIAN P. | MCLEAN HOSPITAL, MA | $1,069,368 | ZMH1 |
| 2021 | Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depression1R61MH125126-01 · under RFA-MH-18-702 | ABBOTT, CHRISTOPHER C | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $756,111 | ZMH1 |
| 2020 | Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression1R61MH121625-01A1 · under RFA-MH-18-702 | FELGER, JENNIFER C | EMORY UNIVERSITY, GA | $1,406,314 | ZMH1 |
| 2020 | Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics1R61MH123754-01 · under RFA-MH-18-702 | CONELEA, CHRISTINE A | UNIVERSITY OF MINNESOTA, MN | $1,248,895 | ZMH1 |
| 2020 | Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum Disorders1R61MH120188-01A1 · under RFA-MH-18-702 | BLUMBERGER, DANIEL M.VOINESKOS, ARISTOTLE NICHOLAS | CENTRE FOR ADDICTION AND MENTAL HEALTH, ON | $1,026,903 | ZMH1 |
| 2020 | Nicotinic Modulation of the Cognitive Control System in Late-Life Depression1R61MH122464-01 · under RFA-MH-18-702 | TAYLOR, WARREN D | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $946,653 | ZMH1 |
| 2020 | Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression (TRIADE)1R61MH122647-01 · under RFA-MH-18-702 | CASSANO, PAOLOIOSIFESCU, DAN VLAD | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $863,648 | ZMH1 |
| 2019 | Morning Light Treatment for Traumatic Stress: the Role of Amygdala Reactivity1R61MH117157-01A1 · under RFA-MH-18-702 | BURGESS, HELEN JULIAZALTA, ALYSON KAY | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $803,761 | ZMH1 |
| 2019 | D-serine augmentation of neuroplasticity-based auditory learning in schizophrenia1R61MH116093-01A1 · under RFA-MH-18-702 | KANTROWITZ, JOSHUA TOLKIEN | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $646,329 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.